Medication Comparison · Updated March 2026

Compounded Semaglutide vs Ozempic: What You Actually Need to Know

Compounded semaglutide costs $149-$299 per month. Brand-name Ozempic costs $892 per month. Both contain the same active ingredient. The price gap raises an obvious question: what are you giving up? I have been tracking GLP-1 pricing and quality data for over a year. This is the honest breakdown of what is different, what is the same, and how to make the right call.

TL;DR

• Same active ingredient. Both contain semaglutide, the GLP-1 receptor agonist developed by Novo Nordisk.
• Compounded is NOT generic. There is no FDA-approved generic semaglutide. Compounded versions are made by compounding pharmacies under FDA shortage rules, not through the standard generic approval process.
• Price gap is massive. Compounded: $149-$299/mo. Ozempic brand: ~$892/mo. For people without insurance, that gap often makes the decision.
• Quality depends on the pharmacy. 503B outsourcing facilities (FDA-inspected, cGMP standards) are much closer to brand manufacturing quality. 503A pharmacies (state-regulated) have less oversight.
• Clinical trial data exists only for the brand-name product. The 14.9% weight loss from the STEP trials was measured with Novo Nordisk’s manufactured semaglutide, not compounded versions.
• The FDA has issued warnings about substandard compounded GLP-1 products. Sourcing matters.

Quick Comparison Table

What Compounded Semaglutide Actually Is

Compounded semaglutide is not a generic. There is no FDA-approved generic version of semaglutide. That is a common misconception worth clearing up immediately.

Here is what it actually is: licensed compounding pharmacies purchase the raw semaglutide active ingredient and formulate it into an injectable medication. They mix the active ingredient with sterile water, a preservative (typically bacteriostatic water with benzyl alcohol), and sometimes additional compounds.

This is legal under the Federal Food, Drug, and Cosmetic Act, specifically Sections 503A and 503B. Compounding pharmacies have been permitted to produce semaglutide because the FDA designated the brand-name versions as being in shortage. While the brand-name drug is in shortage, compounders can produce copies to fill the gap.

The critical distinction from a generic: A generic drug goes through the FDA’s Abbreviated New Drug Application (ANDA) process. The FDA verifies that the generic is bioequivalent to the brand-name product. Compounded medications do not go through this process. No one has tested compounded semaglutide for bioequivalence against Ozempic.

503A vs 503B Pharmacies: This Matters

Not all compounding pharmacies are the same. Understanding the difference between 503A and 503B is the single most important factor in evaluating compounded GLP-1 quality.

503B Outsourcing Facilities

• Registered with the FDA and subject to FDA inspection
• Must follow current Good Manufacturing Practices (cGMP), the same manufacturing standards that apply to traditional pharmaceutical companies
• Can produce larger batches without individual prescriptions
• Must report adverse events to the FDA
• Quality testing required for potency, sterility, and purity

503B facilities are the gold standard for compounding. Their products come closer to brand-name manufacturing quality than anything else in the compounding space. When a telehealth provider says they use an “FDA-inspected pharmacy,” this is typically what they mean.

503A Pharmacies

• State-regulated, not directly FDA-regulated (though the FDA can intervene)
• Each prescription is compounded for an individual patient (cannot batch-produce)
• No cGMP requirement, though many follow their own quality protocols
• Less standardized testing for potency and sterility
• Quality varies significantly from pharmacy to pharmacy

503A pharmacies can produce good products. Many do. But the regulatory framework provides less assurance. The lack of batch testing and FDA oversight means you are relying more heavily on the individual pharmacy’s internal practices.

My recommendation: If you go the compounded route, choose a provider that sources from a 503B outsourcing facility. The quality difference is meaningful.

The Safety Question

This is the section everyone wants to get to. Is compounded semaglutide safe?

The honest answer: it depends on the source.

What the FDA Has Said

The FDA has issued multiple warnings about compounded GLP-1 products. Their concerns include:

• Substandard products with incorrect potency (too much or too little active ingredient)
• Sterility failures leading to contaminated injectables
• Salt form differences (some compounders use semaglutide sodium instead of semaglutide base, which may affect dosing and absorption)
• Products from unregistered sources being marketed online

In 2024 and 2025, the FDA sent warning letters to several compounding pharmacies for quality violations. Some products tested by the FDA contained incorrect concentrations of semaglutide.

What This Means in Practice

The FDA warnings are real and should not be dismissed. At the same time, millions of people have used compounded semaglutide from reputable 503B pharmacies without incident. The risk is not binary (safe vs unsafe). It is a spectrum that depends almost entirely on your source.

Lower risk: Compounded semaglutide from an FDA-inspected 503B outsourcing facility that performs batch testing for potency, sterility, and endotoxins. These pharmacies operate under standards similar to traditional pharmaceutical manufacturers.

Higher risk: Compounded semaglutide from an unknown 503A pharmacy, an online source without clear pharmacy credentials, or any product that ships without a valid prescription. Avoid these.

Clinical Trial Data

All published clinical trial data for semaglutide (the STEP trials, SUSTAIN trials, SELECT trial) used Novo Nordisk’s manufactured product. No independent clinical trials have been conducted on compounded semaglutide. This means the 14.9% weight loss figure, the cardiovascular benefits, and the safety profile data apply specifically to the brand-name drug.

Does compounded semaglutide produce weight loss? Anecdotally, yes. Millions of patients and thousands of prescribers report that it works. But the formal evidence base applies only to the brand product.

Cost Comparison

The cost difference is not subtle. Over a year, compounded semaglutide saves $7,000 to $9,000 compared to brand-name Ozempic without insurance. For many people, that difference is the entire decision.

But here is the flip side: If you have insurance that covers Ozempic for type 2 diabetes, your out-of-pocket cost may be $25-$100/month. At that price, brand-name Ozempic is cheaper than compounded semaglutide and comes with the full FDA manufacturing guarantee.

The people who benefit most from compounded semaglutide are those who: (1) do not have insurance, (2) have insurance that does not cover GLP-1 medications, or (3) want semaglutide for weight loss and their plan excludes weight management drugs.

For a full comparison of all provider pricing, see our cheapest GLP-1 online guide.

Dosing Differences

Ozempic comes in a pre-filled injection pen with precise dose selection. You click to your dose, inject, and you are done. The pen handles the measuring.

Compounded semaglutide typically comes in a multi-dose vial. You draw up the correct amount with a syringe. This requires you (or your provider) to calculate the volume needed based on the concentration of the solution.

This is a practical difference that matters. Drawing from a vial is more error-prone than using a pre-filled pen. If the concentration of your compounded solution is 2 mg/mL and you need 0.5 mg, you draw 0.25 mL. Get the math wrong, and you are injecting the wrong dose.

Some telehealth providers now offer compounded semaglutide in pre-filled syringes, which reduces the dosing error risk. If you are not comfortable with vial-and-syringe dosing, ask your provider about pre-filled options.

The Regulatory Situation (2026)

The legality of compounded semaglutide depends on the FDA’s shortage designation. Here is where things stand:

• February 2025: The FDA declared the semaglutide shortage resolved.
• Legal challenges followed. Compounding pharmacies and telehealth companies challenged the FDA’s determination in court.
• As of early 2026: The regulatory situation remains in flux. Some compounding pharmacies continue to produce semaglutide under various legal arguments. The FDA’s enforcement approach has been evolving.

What this means for patients: compounded semaglutide is still available from many telehealth providers as of March 2026. But the legal basis is less certain than it was during the peak shortage period. The supply could be disrupted if the FDA takes stronger enforcement action.

If you start on compounded semaglutide, have a backup plan. Know what your insurance covers for brand-name options, and understand the pricing for Wegovy (the FDA-approved weight loss version of semaglutide) in case compounded availability changes.

Choose Brand-Name Ozempic If…

• Your insurance covers it. If Ozempic is on your formulary for T2D, the copay may be cheaper than compounded semaglutide.
• You have type 2 diabetes. Ozempic is FDA-approved for T2D with years of clinical trial data behind it.
• You want the highest manufacturing quality. Novo Nordisk’s facility produces under full FDA oversight with validated potency, sterility, and consistency.
• You prefer the convenience of a pre-filled pen. No measuring, no syringes, less room for dosing error.
• You value the clinical trial data. The STEP, SUSTAIN, and SELECT results apply specifically to the brand product.

Choose Compounded Semaglutide If…

• You cannot afford brand-name pricing. At $149-$299/mo vs $892/mo, the savings are substantial.
• Your insurance does not cover any GLP-1 medication. For uninsured patients or those with exclusions, compounded is often the only affordable path.
• You use a provider that sources from a 503B outsourcing facility. This gives you reasonable quality assurance.
• You understand the trade-offs. No formal clinical trial data on the compounded product, variable quality depending on source, and an uncertain regulatory future.

How to Evaluate a Compounded Semaglutide Provider

If you decide to go the compounded route, here is what to check:

1. Ask about the pharmacy type. Is it a 503B outsourcing facility or a 503A pharmacy? 503B is preferred.
2. Request certificates of analysis (COA). Reputable providers can share batch testing results for potency and sterility.
3. Verify the prescription requirement. Any legitimate provider requires a prescription from a licensed prescriber. If someone offers semaglutide without a prescription, walk away.
4. Check the concentration and salt form. Some pharmacies use semaglutide sodium rather than semaglutide base. The dosing may differ. Ask your provider to clarify.
5. Look for ongoing clinical support. You want dose adjustments, check-ins, and a prescriber you can reach. Avoid “ship and forget” operations.

We review dozens of telehealth providers at clearmetabolic.com/reviews/. Each review includes information about the pharmacy they use.

Frequently Asked Questions

Is compounded semaglutide the same as generic Ozempic?

No. There is no FDA-approved generic Ozempic. Compounded semaglutide is produced by compounding pharmacies using the raw semaglutide active ingredient. It has not gone through the FDA’s generic drug approval process (ANDA), which requires proof of bioequivalence. Compounded semaglutide exists under a separate legal framework tied to the FDA’s drug shortage policy.

How do I know if my compounded semaglutide is real?

Ask your provider about the compounding pharmacy. Look for: (1) FDA registration as a 503B outsourcing facility, (2) certificates of analysis showing potency testing for each batch, (3) sterility testing documentation. If your provider cannot or will not share this information, consider switching to one that can.

Will I get the same weight loss on compounded semaglutide?

There is no clinical trial data comparing compounded semaglutide to Ozempic. Anecdotal reports from millions of patients and thousands of prescribers suggest that compounded semaglutide from quality pharmacies produces similar results. But the formal evidence (14.9% weight loss from the STEP 1 trial) applies only to Novo Nordisk’s manufactured product.

What happens if the FDA shuts down compounded semaglutide?

If the FDA takes stronger enforcement action and compounded semaglutide becomes unavailable, your options would be: (1) brand-name Ozempic or Wegovy (if you can access and afford them), (2) switching to a different GLP-1 like compounded tirzepatide (if still available), or (3) working with your prescriber on alternative weight management approaches. This is why having a backup plan matters.

Can I use compounded semaglutide with my insurance?

No. Insurance does not cover compounded medications. If your insurance covers Ozempic (for T2D) or Wegovy (for weight management), those brand-name products will be cheaper than compounded semaglutide after applying your copay. Compounded semaglutide is a self-pay option.

Last updated: March 2026. Pricing and availability may change. This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.